In this issue, we present a review of medical device and in vitro diagnostics/research dealmaking for the fourth quarter of 2007. Our data are derived from Windhover's Strategic Transactions Database.
Amanda Micklus and Maureen Riordan
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Highlights from the Q4 2007 review of medical device and in vitro diagnostics/research dealmaking: there was a boost in medical device acquisitions--with patient monitoring in particular, which accounted for about half the total of this period--capping off an impressive year in medtech M&A activity. Of note in the in vitro diagnostics/research space was glucose monitoring, which brought in 60% of the total GM segment's $160 million in financing for the entire year.